Our campaign wins
With your help, we’re making progress for dementia research and people impacted by the condition.
MPs raise awareness of dementia
Over a dozen MPs come together to hold a Backbench Business Debate to discuss dementia and ways to improve the lives of people living with the condition. The 90 minute session raises several important issues, including Alzheimer’s Research UK’s call for £320m to be put towards research. Four MPs champion the need for additional dementia research funding with two calling for just 1% in the debate.
Rachel Riley takes ‘Just 1%’ campaign to Number 10
Thanks to our incredible supporters, we elevate the call for government to fund more research than ever before! Countdown’s Rachel Riley joins Alzheimer’s Research UK and people impacted by dementia to present our incredible 35,000-strong petition to 10 Downing Street. The petition calls for dementia research funding to increase to 1% of the total cost of dementia.
NHS includes dementia in Long Term Plan
Dementia is included as a priority health area in the strategic plan for the NHS for the upcoming decade. It comes after Alzheimer’s Research UK brings together organisations from across the UK to publish an open letter to the Health Secretary. The letter asked leaders “to put dementia and the millions impacted by the condition at the heart of your priorities”.
35,000 back Alzheimer’s Research UK call for ‘Just 1%’
Nearly 35,000 incredible supporters sign our petition asking the government to increase research spending to 1% of the overall cost of dementia. The number of signatures cause the government to acknowledge and respond to our call. The petition supports our action plan for government that outlines changes needed to improve the lives of people with dementia.
New plan outlines 5 actions for government
We launch our new action plan for government. The report outlines five areas to help improve the lives of people with dementia and bring about life-changing treatments. Our lead call to is to put 1% of the total cost of dementia towards research funding by 2025. Over 100 Campaigners write to their MPs – a huge success in raising awareness about how government can support dementia research.
NHS Health Check to include brain health information
MPs heed cry to back dementia research
Our Campaigners help drive support for an Early Day Motion during Dementia Action Week, recognising the impact of dementia and our mission to bring about the first life-changing treatment by 2025. A total of 34 MPs across six political parties sign the Early Day Motion, helping us understand who can champion our cause in parliament.
PM supports revolutionary early diagnosis effort
Prime Minister Theresa May outlines a new early diagnosis of disease project within the Grand Challenge on Artificial Intelligence in the Industrial Strategy and mentions dementia as part of this work. This announcement aligns with work Alzheimer’s Research UK is doing to change the way we detect the diseases that cause dementia.
1,000th Campaigner joins Alzheimer’s Research UK
Alzheimer’s Research UK calls for help promoting dementia research during the snap general election and the number of people helping us campaign soars! Thanks to you, we now have more people calling for support in government than ever before.
Tory manifesto includes dementia pledge
In the midst of a snap general election, the Conservatives’ election manifesto includes a commitment to invest in dementia research. Alzheimer’s Research UK calls on other political parties to make similar commitments to ensure efforts to power breakthroughs in dementia research remain a priority in the next parliament.
Report shows number of dementia researchers has doubled
Following a boost in research investment in 2010, the number of neurodegeneration researchers in the UK doubles between 2008/9 and 2014/15. This also results in a doubling of the number of research publications, increasing our understanding of the diseases that cause dementia.
Alzheimer’s Research UK hosts roundtable to learn from drug failure
In the wake of the disappointing halt of clinical trials into Alzheimer’s drug solanezumab, Alzheimer’s Research UK brings together leading international researchers, including those who worked on the drug, to discuss learnings from the trials. This was the first time that detailed data from the trial was presented to the scientific community, and the discussions are now being used to help shape future research efforts.
Alzheimer’s Research UK joins government to fund groundbreaking research effort
Alzheimer’s Research UK commits £50m to the UK Dementia Research Institute, which is led by a government investment of £150m. The initiative demonstrates a strong commitment to dementia research and is the largest joint effort in the UK supporting dementia research uniting Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK.
Dementia is made a ‘test case’ for treatment evaluations
Following campaigns from Alzheimer’s Research UK, the new Accelerated Access Review names dementia as a ‘test case’ in evaluating new medicines made available on the NHS. The review considers how to speed up access to new drugs, medical technology and diagnostic tools.
New dementia research fund is announced
Alzheimer’s Research UK joins with the UK Department of Health and major pharmaceutical companies to invest in a global fund to develop new treatment approaches. The Dementia Discovery Fund focuses on exploring new ideas in dementia research, as well as stimulating further global investment in research into the condition.
Challenge on Dementia is renewed
Following the publication of Alzheimer’s Research UK’s Manifesto 2015-2020, which lays out steps needed to achieve the goal of bringing about a life-changing treatment by 2025, the coalition government sets out plans for its second Challenge on Dementia. This includes a commitment to investing £300m in dementia research over five years.
Report reveals dementia hits women hardest
Alzheimer’s Research UK publishes “Women and Dementia: A marginalised majority”, a groundbreaking report that looks at how dementia impacts women. This insightful report stimulates conversation around the world and is referenced by organisations including the Global Alliance for Women’s Brain Health.
Prime Minister welcomes research goal at G8 event
Following ambitions set at the G8 Dementia Summit, Alzheimer’s Research UK pledges to raise £100m for dementia research. Among the projects funded is a pioneering UK Stem Cell Research Centre to enable collaboration between researchers at University of Cambridge and University College London. Prime Minister David Cameron announces this campaign in his speech at a legacy event of the G8 Dementia Summit.
G8 sets ambitious goal for dementia research and treatment
The UK government uses its presidency of the G8 to host the first ever G8 Dementia Summit. At the event, world leaders commit to an ambition to develop a disease-modifying treatment for dementia by 2025.
Challenging government to answer to UK dementia crisis
Alzheimer’s Research UK launches its first report on dementia research capacity, “Defeating Dementia”, revealing a serious lack of dementia researchers in the UK and highlighting the need for a national dementia research strategy. Just two months later, the first Prime Minister’s Challenge on Dementia is launched by Prime Minister David Cameron, including a commitment to double research funding in the UK.